参考文献

［1］Alexander JL，Wilson ID，Teare J，et al.Gut microbiota modulation of chemotherapy efficacy and toxicity.Nat Rev Gastroenterol Hepatol.2017，14（6）：356-365.

［2］Birchenough G，Hansson GC.Bacteria Tell Us How to Protect Our Intestine.Cell Host Microbe.2017，22（1）：3-4.

［3］Gopalakrishnan V，Helmink BA，Spencer CN，et al.The Influence of the Gut Microbiome on Cancer，Immunity，and Cancer Immunotherapy.Cancer Cell.2018，33（4）：570-580.

［4］Gutzeit C，Magri G，Cerutti A.Intestinal IgA production and its role in host-microbe interaction.Immunol Rev.2014，260（1）：76-85.

［5］Hernández-Chirlaque C，Aranda CJ，Ocón B，et al.Germ-free and Antibiotic-treated Mice are Highly Susceptible to Epithelial Injury in DSS Colitis.J Crohns Colitis.2016，10（11）：1324-1335.

［6］Jiang X，Wang J，Deng X，et al.Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.Mol Cancer.2019，18（1）：10.

［7］Johansson ME，Jakobsson HE，Holmén-Larsson J，et al.Normalization of Host Intestinal Mucus Layers Requires Long-Term Microbial Colonization.Cell Host Microbe.2015，18（5）：582-592.

［8］Kim JM，Chen DS.Immune escape to PD-L1/PD-1 blockade：seven steps to success（or failure）.Ann Oncol.2016，27（8）：1492-1504.

［9］Levy M，Kolodziejczyk AA，Thaiss CA，et al.Dysbiosis and the immune system.Nat Rev Immunol.2017，17（4）：219-232.

［10］Li X，Shao C，Han W.Lessons learned from the blockade of immune checkpoints in cancer immunotherapy.J Hematol Oncol.2018，11（1）：31.

［11］Macpherson AJ，de Agüero MG，Ganal-Vonarburg SC.How nutrition and the maternal microbiota shape the neonatal immune system.Nat Rev Immunol.2017，17（8）：508-517.

［12］Pickard JM，Zeng MY，Caruso R，et al.Gut microbiota：Role in pathogen colonization，immune responses，and inflammatory disease.Immunol Rev.2017，279（1）：70-89.

［13］Reboldi A，Cyster JG.Peyer’s patches：organizing B-cell responses at the intestinal frontier.Immunol Rev.2016，271（1）：230-245.

［14］Rooks MG，Garrett WS.Gut microbiota，metabolites and host immunity.Nat Rev Immunol.2016，16（6）：341-352.

［15］Round JL，Mazmanian SK.Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota.Proc Natl Acad Sci U S A.2010，107（27）：12204-12209.

［16］Roy S，Trinchieri G.Microbiota：a key orchestrator ofcancer therapy.Nat Rev Cancer.2017，17（5）：271-285.

［17］Schreiber RD，Old LJ，Smyth MJ.Cancer immunoediting：integrating immunity’s roles in cancer suppression and promotion.Science.2011，331（6024）：1565-1570.

［18］Yang Y.Cancer immunotherapy：harnessing the immune system to battle cancer.J Clin Invest.2015，125（9）：3335-3337.

［19］Yi M，Qin S，Chu Q，et al.The role of gut microbiota in immune checkpoint inhibitor therapy.Hepatobiliary Surg Nutr.2018，7（6）：481-483.

［20］Abreu MT.Toll-like receptor signalling in the intestinal epithelium：how bacterial recognition shapes intestinal function.Nat Rev Immunol 2010，10（2）：131-144.